The ML830(tm) Laser was designed by the team of doctors and leading medical engineers to harness the therapeutic application of advanced low energy laser.
Statistics indicates that 2.4 million visits were made to physicians in office-based practice because of Carpal Tunnel Syndrome (CTS), of which 1 million were made to orthopedic surgeons. In 1999 approximately 366,000 CTS surgeries were performed, according to the American Academy of Orthopedic Surgeons, a 300% increase from 1991; however, both surgical and most non-surgical treatments generally have been unsuccessful in enabling CTS sufferers to return to work.
The ML830 is a non-thermal laser capable of penetrating deep into tissue. Once delivered, the light energy promotes the process of photobiostimulation. In human tissue the resulting photochemical reaction produces an increase in the cellular metabolism rate which expedites cell repair and the stimulation of the immune, lymphatic and vascular systems. The net result is the apparent reduction in pain, inflammation, edema and an overall reduction in healing time.
Studies conducted at General Motors, Baylor College of Medicine and by many other investigators throughout the United States generated data that supports the effectiveness of the ML830 Laser for the treatment of Carpal Tunnel Syndrome. This led to Microlight Corporation receiving 510k approval to market the ML830 for the effective treatment of Carpal Tunnel Syndrome.
The ML830 is also used in ongoing studies in pain relief, arthritis, lower back pain, and repetitive stress injury, tendonitis, sprains, strains, fibromyalgia, post-operative pain, tennis elbow and soft tissue injuries.